Search - tctmd.com

Displaying 41 - 60 of 410

Sort: Relevancy | Date

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Daily News

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Michael O'Riordan

November 29, 2023

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News AHA 2023

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

Todd Neale

November 17, 2023

News Conference News AHA 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Shelley Wood

November 14, 2023

News Conference News AHA 2023

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Shelley Wood

November 13, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

Advertisement

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

April 2024 Dispatch for the CV Team

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference?

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Surgeons Support Proposed Changes to Left Main CAD Guidelines

October 2023 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content